𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma

✍ Scribed by Raviprakash T. Sitaram; Claire J. Cairney; Pawel Grabowski; W. Nicol Keith; Bengt Hallberg; Börje Ljungberg; Göran Roos


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
354 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

DJ‐1 is as a novel regulator of the tumor suppressor PTEN with stimulatory effects on PI3K‐AKT/PKB signaling, one possible target of which is cMyc. The catalytic unit of the telomerase complex, hTERT, can be activated at different levels, including transcriptionally by cMyc and through phosphorylation by AKT/PKB. The aim of the study was to analyze the putative signaling pathway encompassing DJ‐1, cMyc and hTERT in a series of 176 renal cell carcinomas (RCC) and experimentally in cell lines. DJ‐1 mRNA expression was significantly elevated in clear cell RCC (ccRCC) compared with in papillary RCC (pRCC; p = 0.005) and kidney cortex tissue (p < 0.001). ccRCC and pRCC demonstrated higher cMyc RNA levels than in kidney cortex (p < 0.001 for both) as well as increased levels of hTERT RNA (p < 0.001 and p = 0.011, respectively). DJ‐1 was positively correlated to cMyc and hTERT in ccRCC (p < 0.001 and p = 0.019, respectively), but not in pRCC, indicating that this pathway could have a functional significance in ccRCC. siRNA knock down of DJ‐1 induced downregulation of cMyc and hTERT mRNA associated with decreased expression of pAKT and cMyc protein levels. hTERT promoter activity was upregulated after DJ‐1 transfection and this upregulation was inhibited after mutation of the cMyc binding sites. These experimental data support the functional link among DJ‐1, cMyc and hTERT expression as indicated in the tumor material. Neither DJ‐1, cMyc nor hTERT mRNA levels were associated with proliferation (S‐phase fraction), telomere length or prognosis in ccRCC. © 2009 UICC


📜 SIMILAR VOLUMES


Activation of the MN/CA9 gene is associa
✍ Masaki Cho; Karin Grabmaier; Yoshiteru Kitahori; Yoshio Hiasa; Yoshinori Nakagaw 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

The MN/CA9 (G250) gene expressed in the normal alimentary tract in a tissue-specific manner is often activated in renal cell carcinomas. To cast light on the activation mechanism, we examined the methylation status of this gene in seven human renal cell carcinoma cell lines and three normal kidney t

A single nucleotide polymorphism in the
✍ Hiroshi Hirata; Katsusuke Naito; Satoru Yoshihiro; Hideyasu Matsuyama; Yutaka Su 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 63 KB 👁 2 views

## Abstract Matrix metalloproteinase (MMP)‐1 is associated with tumor cell invasion and metastasis, and its promoter polymorphism has been shown to influence the transcriptional level. Our study explored the association between this polymorphism and renal cell carcinoma in a Japanese population. DN

Multiple drug resistance gene expression
✍ Christoph F. Rochlitz; Hartmut Lobeck; Stefan Peter; Jürgen Reuter; Benno Mohr; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Overexpression of p170 glycoprotein, the product of the multiple drug resistance (mdr) gene, has been associated with resistance to various cytotoxic drugs used in the treatment of human neoplasms. Normal renal epithelial cells express p170 as a function of their secretory capacity. Because renal ce

p21WAF1/Cip1 expression is associated wi
✍ Nadal, Alfons; Jares, Pedro; Cazorla, Maite; Fernández, Pedro L.; Sanjuan, Xavie 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

p21 WAF1/Cip1 is a recently identified gene involved in cell cycle regulation through cyclin-CDK-complex inhibition. The expression of this gene in several cell lines seems to be induced by wild-type, but not mutant, p53. p21 WAF1/Cip1 expression has been studied at both mRNA and protein levels in a